1,850
Participants
Start Date
June 25, 2024
Primary Completion Date
December 29, 2031
Study Completion Date
December 29, 2031
Treatment of transthyretin (ATTR) amyloidosis in observational study setting
Data will be collected on patients with ATTR amyloidosis in a real-world setting
RECRUITING
Research Site, New York
RECRUITING
Research Site, New York
RECRUITING
Research Site, Berlin
RECRUITING
Research Site, Manhasset
RECRUITING
Research Site, Danville
RECRUITING
Research Site, Philadelphia
RECRUITING
Research Site, Philadelphia
RECRUITING
Research Site, Washington D.C.
RECRUITING
Research Site, Richmond
RECRUITING
Research Site, Durham
RECRUITING
Research Site, Greenville
RECRUITING
Research Site, Hanover
RECRUITING
Research Site, Nashville
RECRUITING
Research Site, Germantown
RECRUITING
Research Site, Cologne
RECRUITING
Research Site, Aachen
RECRUITING
Research Site, Milwaukee
RECRUITING
Research Site, Mainz
RECRUITING
Research Site, Rochester
RECRUITING
Research Site, Frankfurt am Main
RECRUITING
Research Site, Chicago
RECRUITING
Research Site, St Louis
RECRUITING
Research Site, Kansas City
RECRUITING
Research Site, Homburg
RECRUITING
Research Site, Dallas
RECRUITING
Research Site, Los Angeles
RECRUITING
Research Site, La Jolla
RECRUITING
Research Site, San Francisco
RECRUITING
Research Site, San Francisco
RECRUITING
Research Site, Seattle
RECRUITING
Research Site, New Haven
RECRUITING
Research Site, Indianapolis
RECRUITING
Research Site, Boston
NOT_YET_RECRUITING
Research Site, Boston
RECRUITING
Research Site, Boston
RECRUITING
Research Site, New Brunswick
RECRUITING
Research Site, Vancouver
RECRUITING
Research Site, Vancouver
RECRUITING
Research Site, Halifax
RECRUITING
Research Site, London
RECRUITING
Research Site, Toronto
NOT_YET_RECRUITING
Research Site, Rimouski
NOT_YET_RECRUITING
Research Site, Würzburg
RECRUITING
Research Site, Glasgow
RECRUITING
Research Site, London
Lead Sponsor
Collaborators (1)
ICON plc
INDUSTRY
AstraZeneca
INDUSTRY